A Multicentre Randomised Phase III Trial Comparing Pembrolizumab Versus Standard Chemotherapy for Advanced Pre-treated Malignant Pleural Mesothelioma
Phase of Trial: Phase III
Latest Information Update: 13 Nov 2017
At a glance
- Drugs Pembrolizumab (Primary) ; Gemcitabine; Vinorelbine
- Indications Mesothelioma
- Focus Therapeutic Use
- Acronyms PROMISE-meso
- 07 Nov 2017 Status changed from not yet recruiting to recruiting.
- 28 Jul 2017 Planned initiation date changed from 1 May 2017 to 1 Sep 2017.
- 21 Apr 2017 Planned End Date changed from 1 Nov 2020 to 1 Dec 2020.